Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1) Diabetes Care
49 But this study did not find this effect, which may be due to the fact that the subjects were prefrail and the inflammatory mediator level was not high, such as in the hemodialysis and HIV patients, and it may be due to the doses and intervention periods
[DOI] [PMC free article] [PubMed] [Google Scholar] 101.Loomba R, Hartman ML, Lawitz EJ, et al
10.1016/j.jns.2017.08.3235 284 LiuP.WuL.PengG.HanY.TangR.GeJ.et al
J Clin Invest 110(1):4352
All transfection mixes were made in Opti-MEM reduced serum medium (31985-047